Bacterial Lysates in sickly children in periods of acute respiratory infections morbidity increase
114 children with acute respiratory diseases, aged from 8 months to 10 years old were observed. The base group was comprised of 54 children who were treated with IRS ®19. The control group was comprised of 60 children. Adding of IRS ®19 to the treating protocols of children with ARD proved to reliably reduce the clinical symptoms and prevent such complications as sinusitis, otitus and bronchitis